Navigation Links
Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research
Date:3/17/2010

BOISE, Idaho, March 17 /PRNewswire/ -- A new professional services company has been launched focused on accelerating the connections of university-based bioscience research with commercial development opportunities. Bioscience Bridge, LLC was formed by Michelle Travis, principal and managing director, along with Mark Stinson, chief strategic officer.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100317/CG72294LOGO)

Bioscience Bridge is also supported by a team of consultants with experience in product strategy, marketing, business development, life science, legal, licensing and commercialization.

According to Ms. Travis, "We know that some of the best bioscience research comes from universities. Bioscience Bridge helps tech transfer offices at these universities get the technology out into the marketplace. This may be in the form of a start-up company or licensing agreements."

She adds, "We have the industry experience to bring the right companies to the universities."

University offices of technology transfer (OTT) have contacted Bioscience Bridge when they have a technology that is "stuck" or are looking for a technology portfolio evaluation.

Bioscience Bridge has several proprietary processes to assist OTTs:

  • Evaluation – using B.E.A.M.S.® to analyze university's specific technology or entire portfolio
  • Strategy – facilitating a Strategic GPS® to guide early stage technologies
  • Promotion – getting the right message in the right medium to the right people
  • Negotiation – assisting with the contract terms process leading to commercial agreements

Bioscience Bridge works with universities and life science companies around the world. They will be attending the AUTM 2010 Annual Meeting in New Orleans March 18-21, BIO International 2010 in Chicago May 3-6, and the Licensing Executives Society Spring Meeting in Boston, May 19-21. More information about Bioscience Bridge services, capabilities, and connections is online at www.biosciencebridge.com

About Bioscience Bridge, LLC:

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we support tech transfer offices with our bioscience industry experience and a proven process in the evaluation, strategy, promotion and negotiation of licensing, collaboration or start up arrangements. The agency is a member of Association of Technology Managers (AUTM) and the Licensing Executives Society (LES). More information is on the Bioscience Bridge website at www.biosciencebridge.com

SOURCE Bioscience Bridge, LLC

Back to top

RELATED LINKS
http://www.biosciencebridge.com

'/>"/>

SOURCE Bioscience Bridge, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
2. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
3. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
4. YM BioSciences closes US$17.5 million financing
5. YM BioSciences to raise approximately US$15 million
6. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
7. TEI Biosciences PriMatrix(TM) Awarded Seal of Approval by American Podiatric Medical Association
8. KGI Study Reveals Diverse and Vibrant Regional Bioscience Industry
9. YM BioSciences presents CYT387 and CYT997 data at international cancer conference
10. YM BioSciences granted two US patents for AeroLEF(R)
11. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:4/18/2017)... 18, 2017  Socionext Inc., a global expert in SoC-based imaging ... server, the M820, which features the company,s hybrid codec technology. A ... Tera Probe, Inc., will be showcased during the upcoming Medtec Japan ... at the Las Vegas Convention Center April ... Click here for ...
(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
Breaking Biology News(10 mins):